Andrew Olaye

Andrew Olaye has extensive experience in market access and partnerships in the pharmaceutical industry. Andrew has held senior roles at companies such as Orchard Therapeutics, BioMarin Pharmaceutical Inc., Vertex Pharmaceuticals, Grünenthal Group, and LA-SER EUROPE. Their work has focused on health economics, market access, and reimbursement strategies within the European market.

Andrew Olaye holds an MSc in Health Economics, Policy and Management from The London School of Economics and Political Science (LSE). Andrew also earned an MPharm in Pharmacy from The School of Pharmacy, University of London, and a PhD in Pharmacy with a focus on Tissue Engineering / Regenerative Medicine from the University of Nottingham.